Farag F. Sherbiny

Design, synthesis and anticancer evaluation of 1H-pyrazolo[3,4-d]pyrimidine derivatives as potent EGFRWT and EGFRT790M inhibitors and apoptosis inducers

Ahmed A. Abdel Gaber, Ashraf H. Bayoumi, Ahmed El-morsy et al. · Bioorganic Chemistry · 2018 · 134 citations

Medicine, Medicinal Chemistry, Oncology +17

Synthesis, characterization and molecular docking studies of thiouracil derivatives as potent thymidylate synthase inhibitors and potential anticancer agents

Abeer M. El‐Naggar, Mohsen M. Abou-El-Regal, Souad A. El‐Metwally et al. · Molecular Diversity · 2017 · 76 citations

Pharmacy, Medicinal Chemistry, Pharmacology +12

Pharmacophore‐linked pyrazolo[3,4‐<i>d</i>]pyrimidines as EGFR‐TK inhibitors: Synthesis, anticancer evaluation, pharmacokinetics, and in silico mechanistic studies

Ahmed A. Abdel Gaber, Ahmed El-morsy, Farag F. Sherbiny et al. · Archiv der Pharmazie · 2021 · 74 citations

Pharmacy, Medicinal Chemistry, Pharmacology +17

Unravelling the anticancer potency of 1,2,4-triazole-N-arylamide hybrids through inhibition of STAT3: synthesis and in silico mechanistic studies

Abdallah Turky, Ashraf H. Bayoumi, Farag F. Sherbiny et al. · Molecular Diversity · 2020 · 53 citations

Pharmacy, Medicinal Chemistry, Pharmacology +12

Ligand-Specific Binding and Activation of the Human Adenosine A_2BReceptor

Dominik Thimm, Anke C. Schiedel, Farag F. Sherbiny et al. · Biochemistry · 2013 · 42 citations

Medicine, Medicinal Chemistry, Pharmacology +17